Document |
Document Title |
WO/2002/076972A1 |
Novel compounds for searching out dioxin-decomposing organisms or the like easily and simply. Specifically, novel dioxin analogues of formulae (1) and (2).
|
WO/2002/074738A2 |
The present application describes novel spiro-cyclic $g(b)-amino acid derivatives of formula (I) or pharmaceutically acceptable salt forms thereof, wherein ring B is a 3-13 membered carbocycle or heterocycle, ring C forms a 3-11 membered...
|
WO/2002/072567A2 |
A compound of the general formula (I) and method for preparing and using the compound of formula (I).
|
WO/2002/070128A1 |
A method for producing unsaturated cyclic ethers of general formula (I) wherein Z represents (CHR?4¿)¿q?- or (CHR?4¿)¿q?-0-, q 0, 1, 2 or 3 and R?1¿, R?2¿, R?3¿, R?4¿ represent hydrogen or C¿1?- C¿4?-alkyl, by reacting dioles o...
|
WO/2002/070509A2 |
The present invention relates to chemical compounds, pharmaceutical compositions comprising said compounds, uses of said compounds and compositions, methods of treatment employing said compounds and compositions, and processes for prepar...
|
WO/2002/070508A2 |
The invention provides a process for producing glycolide by depolymerization by heating of a glycolic acid oligomer in the presence or absence of a solvent, which process ensures stable depolymerization. The depolymerization reaction is ...
|
WO/2002/068367A1 |
The present invention generally relates to methods of inhibiting ethylene responses in plants and plant materials, and particularly relates to methods of inhibiting various ethylene responses including plant maturation and degradation, b...
|
WO/2002/064582A1 |
A process for producing 2,5-dihydroxy-1,4-dioxane, which is represented by the formula (III), characterized by reacting an aralkyloxyacetal compound represented by the general formula (I) with hydrogen in the presence of a hydrogenolysis...
|
WO/2002/064545A1 |
The present invention relates to acylated indanyl amines according to the general formula (I) where R?1¿-R?4¿ have the meanings given in the description, A is CH¿2? CHOH or CH-(C¿1?-C¿3?-alkyl), B is CH¿2? or CH-(C¿1?-C¿3?-alkyl)...
|
WO/2002/060891A1 |
A process for consistently producing lactide from ammonium lactate obtained by lactic acid fermentation; and a process for consistently producing polylactic acid from ammonium lactate obtained by lactic acid fermentation are provided. Na...
|
WO/2002/060378A2 |
The invention describes substituted aryl compounds that are cyclooxygenase 2 (COX-2) selective inhibitors and compositions comprising at elast one cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that ...
|
WO/2002/059132A1 |
Novel compounds of Formula I and Formula II (below): formula (I) wherein R¿a? is selected from the group consisting of -CH¿2?-OCH¿3?, -CH¿2?-OCH¿2?CH¿3?, -CH(CH¿3?)OCH¿2?CH¿3?, -CH¿2?-OCH¿2?CH¿2?-OCH¿3?, -CH¿2?OCH¿2?CH¿2?...
|
WO/2002/058631A2 |
Primary intermediates for hair coloring compositions for oxidative dyeing of hair are compounds of the formula (1): wherein R is hydrogen, hydroxy, nitro, amino, halogen, C¿1? to C¿5? alkyl or haloalkyl, C¿1? to C¿5? alkoxy, C¿1? to...
|
WO/2002/059105A1 |
Compounds represented by the general formula (|) or salts thereof: (|) wherein m is an integer of 0 to 4; R?1¿, R?2¿, R?3¿, and R?4¿ are each independently hydrogen, substituted or unsubstituted lower alkyl, or the like; R?5¿ is hyd...
|
WO/2002/057251A2 |
The invention relates to a process for the preparation of a substituted alkene of formula (I) wherein R¿1?, R¿2? and R¿3? are independently of each other a protecting group for a hydroxy group or hydrogen and R¿4? is phenyl which is ...
|
WO2002042250B1 |
The invention concerns the field of synthesis organic chemistry applied to the pharmaceutical field and concerns novel derivatives of 4-hydrxoybutanoic acid and of its higher homologue, 5-hydroxypentanoic acid, their crotonic homologues,...
|
WO/2002/048073A1 |
The invention relates to a method for producing compounds having at least one -CF¿2?-O bridge per molecule, according to which: a) an acid is added to at least one ketene dithioketal; b) the obtained bis(alkylthio)carbenium salt is reac...
|
WO/2002/048085A1 |
A process for production with high productivity which comprises efficiently decomposing a fluorinated ester compound at a low temperature and a high reaction rate. In the process, a fluorinated ester compound having a decomposable ester ...
|
WO/2002/048081A1 |
The invention relates to liquid crystalline compounds of formula (I) wherein R?1¿, R?2¿, A?1¿, A?2¿, A?3¿, A?4¿, Z?1¿, Z?2¿, a, b and c have the designations cited in claim 1. The invention also relates to liquid crystalline medi...
|
WO/2002/046141A2 |
The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for...
|
WO/2002/046172A2 |
The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for...
|
WO/2002/046150A2 |
Compounds which mimic the chemical and/or biological activity of discodermolide are provided and intermediates useful in their preparation.
|
WO/2002/046181A2 |
The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for...
|
WO/2002/044132A1 |
A process for the preparation of (S)-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxy
-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzendicarboxamide (iopamidol) starting from 5-amino-N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-tr...
|
WO/2002/040446A1 |
A novel class of compounds of the general formula (I): wherein Z is arylene or a divalent radical derived from a 5 or 6 membered heteroaromatic ring E is which act to antagonize the action of the glucagon hormone on the glucagon receptor...
|
WO2001042179A9 |
Compounds which mimic the chemical and/or biological activity of discodermolide are provided and intermediates useful in their preparation.
|
WO/2002/040444A1 |
Novel compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any di...
|
WO/2002/040445A1 |
A novel class of compounds of the general formula (I): wherein B is (1), (2), (3) or (4), Z is arylene or a divalent radical derived from a 5 or 6 membered heteroaromaic ring containing 1 or 2 heteroatoms selected from nitrogen, oxygen a...
|
WO/2002/038537A1 |
Novel indanylidene compounds can be used as UV-A filters in cosmetic agents for protecting skin and hair as well as for technical applications.
|
WO/2002/036555A1 |
Novel sulfamides of formula (I) are disclosed. The compounds exert an inhibitory action on the processing of APP by gamma-secretase, and are therefore useful in the treatment or prevention of Alzheimer's disease.
|
WO/2002/032373A2 |
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for t...
|
WO/2002/032872A1 |
Compounds represented by the general formula (|) or salts thereof, or hydrates of both: (|) wherein A?g¿ is an optionally substituted 5- to 14-membered heterocyclic group, or the like; X?g¿ is O-, -S-, or the like; Y?g¿ is optionally ...
|
WO/2002/030929A1 |
Pleuromutilin compounds of the formula (A) & (B) are of use in anti-bacterial therapy.
|
WO/2002/028823A1 |
The present invention relates to compounds of formula (I), in which R1, R1, A and B have the meanings indicated in the claims. The compounds of formula (I) are valuable pharmacologically active compounds. They exhibit a strong antithromb...
|
WO/2002/028820A1 |
The present invention relates to a compound of formula (I) in which X, A, T, Y, G and R are as defined in Claim (1).
|
WO/2002/028396A1 |
The present invention relates to formulations for reducing or eliminating toxicity of environmental hormone containing as detoxifying agent ursodeoxycholic acid, or pharmaceutically acceptable salts or esters thereof.
|
WO/2002/028776A1 |
The additive compound of a carboxylic acid and a halide or of a rare earth or gallium halogenocarboxylate of the same acid is obtained by a method which consists in reacting with HX, X representing a halogen, and in a solvent selected am...
|
WO/2002/024632A2 |
The invention relates to a compound of formula (I), wherein all variables are as defined herein, and pharmaceutically acceptable salts or solvates thereof. The compounds of formula (I) are useful as LXR agonists.
|
WO/2002/024613A2 |
The present invention relates to certain resorcinol derivatives and their use as skin lightening agents.
|
WO/2002/024622A1 |
According to a novel method, $g(v)-ketocarboxylic acid derivatives of formula (I), wherein R?1¿, R?2¿, R?3¿ and n have the meanings given in the description, are obtained by reacting compounds of formula (II) with compounds of formula...
|
WO/2002/022556A1 |
Amide derivatives represented by the following general formula (1) which have a C5$g(a) receptor antagonism, wherein each symbol has the meaning as defined in the description. These amide derivatives, optically active isomers thereof or ...
|
WO/2002/022240A1 |
A reactor (100) for the plasma assisted treatment of effluent gases such as exhaust from internal combustion engines, and effluent gases from industrial processes and incineration. The reactor includes a stage for the plasma-assisted pro...
|
WO/2002/022694A1 |
Catalyst compositions useful for the polymerization of olefins are disclosed. These compositions comprise a Group 8-10 metal complex comprising a bidentate or variable denticity ligand comprising two nitrogen donor atoms independently su...
|
WO/2002/020510A1 |
The invention concerns novel acid-sensitive compounds comprising at least a hydrophilic substituent and a cyclic orthoester which is acid-sensitive, and their salts. Said compounds are useful for forming conjugates (liposomes, complexes,...
|
WO/2002/020528A2 |
Plastic additives which are useful as nucleating agents and which are especially useful for improving the optical properties of polymeric materials are provided. More particularly, this invention relates to certain alkyl (or alkoxy) subs...
|
WO/2002/018417A1 |
The invention is directed to nucleophile-stable thioester generating compounds comprising an orthothioloester or a carboxyester thiol, methods of production and use. The compounds and methods have wide applicability in organic synthesis,...
|
WO/2002/018323A2 |
Compound of formula (I) or therapeutically acceptable salts thereof, are protein tyrosine kinase PTP1B inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are dis...
|
WO/2002/018321A2 |
Compound of formula (I) or therapeutically acceptable salts thereof, are protein tyrosine kinase PTP1B inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are dis...
|
WO/2002/016311A1 |
Carboxylic acid derivatives represented by the following general formula (I) and nontoxic salts thereof: (I) wherein R?1¿ represents COOH, COOR?6¿, etc.; A represents alkylene, etc.; R?2¿ represents alkyl, alkenyl, alkynyl, etc.; B re...
|
WO/2002/014303A1 |
The invention provides a process for the preparation of cyclic esters by depolymerization of aliphatic polyesters which comprises heating under normal or reduced pressure a mixture containing an aliphatic polyester and a specific polyalk...
|